FDA — authorised 4 November 1998
- Application: NDA020747
- Marketing authorisation holder: CEPHALON
- Local brand name: ACTIQ
- Indication: TROCHE/LOZENGE — TRANSMUCOSAL
- Status: approved
🇺🇸 ACTIQ® in United States
FDA authorised ACTIQ® on 4 November 1998
Marketing authorisation
Other Pain Management approved in United States
Frequently asked questions
Is ACTIQ® approved in United States?
Yes. FDA authorised it on 4 November 1998.
Who is the marketing authorisation holder for ACTIQ® in United States?
CEPHALON holds the US marketing authorisation.